x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Stock Movers

Listen for five-minute conversations on today"s biggest winners and losers in the stock market. Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

news business news

All Episodes

4:18

Nvidia Agrees to Groq Licensing Deal; India's Coforge...

Stock Movers ·

2025/12/26

On this episode of Stock Movers:- Shares of Nvidia (NVDA) edge higher in the premarket session as the company agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products.- Shares of Indian technology services provider Coforge Ltd. (COFORGE IN) declined ahead of the US market open after the company agreed to buy Encora at an enterprise value of $2.35 billion

en-US

4:15

Nvidia Edges Higher; Sidus Space Rallies; Biohaven...

Stock Movers ·

2025/12/26

On this episode of Stock Movers:- Shares of Nvidia (NVDA) edge higher in the premarket session as the company takes agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. - Shares of Sidus Space (SIDU) rallied as much as 30 percent ahead of the US market open after the Cape Canaveral, Florida-based space and defense tech company announced plans to

en-US

3:38

Nike Jumps, Costco Upgraded, Dynavax Soars

Stock Movers ·

2025/12/24

- Nike (NKE) shares got a boost on Wednesday after a filing showed that Apple CEO Tim Cook purchased $2.95 million worth of shares on Dec. 22. Cook is Nike’s lead independent director and served as a director since 2005, according to the company’s website. The filing shows Cook purchased 50,000 Class B common stock at a weighted average price of $58.97.- Costco (COST) rose after receiving an upgrade for Christmas, as Northcoast Research analyst Charles Cerankosky raised the

en-US

3:24

Intel Falls, Dynavax Climbs, Snowflake Slides

Stock Movers ·

2025/12/24

- Intel (INTC) shares fell Wednesday after a report said that Nvidia Corp. halted a test to use Intel’s production process to make advanced chips. Nvidia recently tested the so-called 18A process but stopped moving forward, Reuters reported, citing two unidentified people familiar with the matter. Spokespeople for Nvidia and Intel didn’t immediately respond to requests for comment. An Intel spokesperson told Reuters that the company’s 18A manufacturing technologies are

en-US

4:40

Intel Declines; Dynavax Rallies; Nike Ticks Higher

Stock Movers ·

2025/12/24

On this episode of Stock Movers:- Shares of Intel (INTC) fell in the early session after Reuters reported that Nvidia halted a test that uses the chip manufacturer’s 18A technology to produce its chips. Nvidia recently tested whether it could manufacture its chips using Intel’s 18A production process but stopped moving forward, Reuters reported, citing two people familiar with the matter. Nvidia did not respond to Reuters’ request for comment, while an Intel spokesperson told

en-US

3:55

Dynavax Soars After Sanofi Acquistion; Intel Falls on...

Stock Movers ·

2025/12/24

On this episode of Stock Movers:- Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofiagreed to buyDynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. Thestatementon Wednesday came minutes after Sanofi said theUS Food and Drug Administrationhad surprisingly

en-US

4:48

BP Spin Off, Abivax's 1600% Gains, B&M's Woes

Stock Movers ·

2025/12/24

On This episode of Stock Movers:- BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.- French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains- B&M's stock has fallen 56% in 2025, extending the previous year’s 34% drop, as the firm

en-US

4:50

BP Spin Off, Sanofi Down, Fresnillo Up

Stock Movers ·

2025/12/24

On This episode of Stock Movers:- BP Plc agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.- Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as the French drugmaker tries to expand a vaccines business currently anchored by its flu shot franchise.- Fresnillo and other european mining stocks may be active on Wednesday as gold rises above $4,500 an ounce for the first time on escalating tensions

en-US

6:27

Novo Nordisk Rallies, ServiceNow Dips, Sable Rises

Stock Movers ·

2025/12/23

On this episode of Stock Movers:- Novo Nordisk (NVO) shares rallied in trading today following the drugmaker getting US approval to sell a pill version of its blockbuster obesity shot Wegovy. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. The pill is crucial for Novo’s strategy to take on Eli Lilly, which has said its own oral obesity drug could

en-US

4:53

Novo Nordisk Rallies, Johnson & Johnson Slides,...

Stock Movers ·

2025/12/23

On this episode of Stock Movers:- Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered. Shares continued to rally in New York trading on

en-US

2:39

Novo Nordisk Soars, Johnson & Johnson Drops,...

Stock Movers ·

2025/12/23

On this episode of Stock Movers:- Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their body weight over 64 weeks.- Johnson & Johnson (JNJ) was ordered to pay about $1.56 billion to a

en-US

4:11

Novo Nordisk Soars, Albermarle Climbs , Huntington...

Stock Movers ·

2025/12/23

On this episode of Stock Movers:- Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered.- Copper hit a fresh all-time high above

en-US

4:29

Novo Soars on Wegovy Pill Approval; Huntington...

Stock Movers ·

2025/12/23

On this episode of Stock Movers:- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.- Shares of naval shipmaker

en-US

4:08

Novo Soars on Obesity Pill Approval; Huntington...

Stock Movers ·

2025/12/23

On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. - Shares of naval

en-US

4:46

Novo Nordisk's Pill, Ryanair Fined, Akzonobel's Activist

Stock Movers ·

2025/12/23

On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Ryanair was fined more than €255 million ($300 million) by Italy’s antitrust watchdog for allegedly using an “abusive strategy” to thwart third-party travel agencies. - Cevian Capital raises its total holding in Akzo Nobel NV to 10.15% from ~5%, according to a filing

en-US

4:40

Novo Nordisk's Pill, Orsted Winded, Pets At Home Up

Stock Movers ·

2025/12/23

On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday. - Pets at Home Group named James Bailey, the former managing director of

en-US

5:22

Warner Bros. Discovery Rises, First Solar Rallies,...

Stock Movers ·

2025/12/22

On this episode of Stock Movers: - Warner Bros. Discovery (WBD) shares rallied in trading today after word that Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Paramount has been aggressively pursuing Warner Bros. for months and Ellison was taken by surprise when the board agreed to a deal with Netflix for $82.7 billion for the streaming and

en-US

4:28

Warner Bros. Discovery Rises, First Solar Soars,...

Stock Movers ·

2025/12/22

On this episode of Stock Movers:- Warner Bros. Discovery (WBD) shares rose on news that Larry Ellison is throwing his personal fortune behind Paramount Skydance’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Both suitors moved on Monday to strengthen the financial backing for their offers, though they stopped short of increasing their bids. Netflix refinanced a portion of its planned $59 billion of debt as a way to ensure

en-US

2:50

WBD Up on Ellison's Guarantee, Marvell Technology...

Stock Movers ·

2025/12/22

On this episode of Stock Movers:- Warner Bros Discovery (WBD) shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher.- Marvell Technology (MRVL) shares are up 2.1% in premarket trading, after Citi opened a positive catalyst watch on the chipmaker ahead of next month’s CES

en-US

4:50

WBD Up on Ellison's Guarantee, Janus Henderson...

Stock Movers ·

2025/12/22

On this episode of Stock Movers:- Warner Bros Discovery shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher.- Nelson Peltz’s Trian Fund Management and General Catalyst agreed to buy asset manager Janus Henderson Group (JHG) for about $7.4 billion. Shareholders will receive $49

en-US

2,105 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci